As of December 2019
They have 2 fund offerings live
- Portfolio Index Fund, OurCrowd 50 (OC50)
- A hyper-diversified investment vehicle, enabling investors to participate in the next 50 offerings in which OurCrowd invests at least $1M. The fund guarantees participation in oversubscribed and exclusive investments that fit this criteria.
- Second Continuity fund (OC2 II)
- Follow-on round focused of OurCrowd’s most promising portfolio companies. OurCrowd is able to provide access to follow-on rounds in these select OurCrowd portfolio companies by taking advantage of OurCrowd’s un-exercised pro-rata rights. Guidelines require that investments be made solely in follow-on rounds with higher valuations, led by strong institutional, strategic or financial investors.
Digital HealthFund Qure is the first exclusively focused digital health fund: The fund will focus on Seed and Series A rounds investing in innovative digital health startups. The fund is dedicated to the rapidly developing digital health market valued globally at $70 billion US in 2015 and projected to be over $230 billion US by 2020.
OurCrowd Qure has established a collaboration with Johns Hopkins University to provide validation of value. “We are excited about the opportunity to collaborate with OurCrowd to bring new companies and novel ideas to market,” said Christy Wyskiel, Senior Advisor to the President and head of Johns Hopkins Technology Ventures. “We feel these companies will enrich the innovation ecosystem in and around Johns Hopkins.”
The fund will be led by managing partners Allen Kamer and Dr. Yossi Bahagon. Kamer was co-founder of Humedica, a transformative population health and analytics company, which was acquired by UnitedHealth. Most recently, Kamer served as the Chief Commercial Officer of Optum Analytics (a division in Optum, UnitedHealth Group’s health services company), a position he assumed following the acquisition. Previously, he was a director at the healthcare investment bank, Leerink Swann (now Leerink Partners)
We are delighted that Allen and Yossi will be joining the team and bringing their extensive healthcare management and entrepreneurial experience to the Fund,” said Medved. “Sophisticated investors are seeking an array of avenues to deploy their capital. We believe offering a sector fund dedicated exclusively to investing in digital health companies that is connected to the OurCrowd platform offers a unique capability that is highly attractive.” "I am excited to join the OurCrowd team and to collaborate with Dr. Bahagon to launch this Fund,” said Kamer.